Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

NIH selects Southern Research Institute to support MLPCN

Southern Research Institute : 05 September, 2008  (Company News)
The National Institutes of Health (NIH) has selected the Southern Research Institute to participate in the newly-funded Molecular Libraries Probe Production Center Network (MLPCN).
The MLPCN - a collaborative research network - is part of the Molecular Libraries Program which is designed to benefit human health, broaden scientific knowledge of the human genome and validate future targets for drug discovery.

Southern Research will receive $14.7 million in NIH grant support during the six-year period to conduct work at Southern Research's Specialized Biocontainment Screening Center (SRSBSC).

The SRSBSC will provide the results from five assays per year that identify protein function and signaling pathways in pathogen-infected cells which will lead to hit identification and characterization. The SRSBSC will provide a platform for assays requiring Biosafety Levels 2 and 3 for high throughput screening and secondary assays.

'While the focus of the SRSBSC team is on virology, our infrastructure would support the screening of other pathogens requiring containment,' said Colleen Jonsson, principal investigator for the SRSBSC.

'Winning this award is a testament to Southern Research's strong capabilities in infectious disease research, and reinforces Southern's commitment to the MLPCN and the initiatives within the National Institutes of Health's Roadmap for Medical Research,' said Wilson Blaine Knight, PhD, vice president, Drug Discovery, Southern Research Institute. 'These initiatives place data in the public domain which will enhance the success in the discovery and development of significant medicines to help improve health and therefore the quality of our lives.'

SRSBSC efforts should accelerate the discovery of targets for therapeutic intervention, and reveal biomarkers of infection that could be used for early diagnosis of viral infections. There are more than 300 human viruses that have no treatment, vaccine or antiviral, and there are only 62 drugs approved by the FDA for the treatment of six different viral illnesses caused by hepatitis B and C, herpes, HIV, influenza, and respiratory syncytial viruses. Of these, almost half are for the treatment of HIV/AIDS. The remaining drugs offer treatments that target the other five viruses. Therefore, identifying new molecular probes will promote the discovery of new approaches for therapeutic intervention.

Southern Research was one of nine US-based research facilities chosen to participate in the six year programme. The MLPCN will offer high throughput screening (HTS) and probe development resources to public and private researchers via the general NIH Program Announcement (PAR-08-035: Solicitation of Assays for HTS in the Molecular Libraries Probed Production Centers Network (MLPCN) (NOT-RM-08-022).

The eight other institutions who also received grants as part of the Molecular Libraries Probe Production Center Network include:

- Burnham Center for Chemical Genomics, Burnham Institute, La Jolla, California.

- Broad Institute Comprehensive Screening Center, Broad Institute, Cambridge, Massachusetts.

- Comprehensive Center for Chemical Probe Discovery and Optimization at Scripps Research Institute, Scripps Institute, San Diego, California.

- Johns Hopkins Ion Channel Center, Johns Hopkins University, Baltimore, Maryland.

- NIH Chemical Genomics Center, NIH/NHGRI, Rockville, Maryland.

- University of Kansas Specialized Chemistry Center, University of Kansas, Lawrence, Kansas.

- University of New Mexico Center for Molecular Discovery, University of New Mexico, Albuquerque, New Mexico

- Vanderbilt Specialized Chemistry Center for Accelerated Probe Development, Vanderbilt University, Nashville, Tennessee.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo